查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1387329

慢性肾臟病(CKD) 市场报告：2030 年趋势、预测与竞争分析

Chronic Kidney Disease Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

慢性肾臟病(CKD) 趋势与预测

预计到 2030 年，全球慢性肾臟病(CKD) 市场将达到 836 亿美元，2024 年至 2030 年年复合成长率为 6.5%。该市场的主要驱动因素是慢性肾臟病（CKD）患者数量的增加以及技术先进的产品和诊断测试的可用性。全球慢性肾臟病（CKD）市场前景广阔，医院和透析中心市场蕴藏未来性。

慢性肾臟病(CKD) 市场洞察

Lucintel 预测，在预测期内，药品的成长将高于新药和新疗法的推出，以帮助医疗专业人员有效治疗患者。

在这个市场中，医院预计将出现高速成长，因为它们配备了 CKD 治疗和管理所需的先进设备。

由于大量患者的存在以及对优质医疗保健的需求不断增加，预计亚太地区在预测期内将出现最高的增长。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球慢性肾臟病（CKD）市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球慢性肾臟病（CKD）市场趋势（2018-2023）与预测（2024-2030）
  • 按治疗分類的全球慢性肾臟病(CKD) 市场
    • 药品
    • 透析
  • 全球慢性肾臟病(CKD) 市场（依最终用途）
    • 医院
    • 透析中心
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 全球慢性肾臟病（CKD）市场按地区划分
  • 北美慢性肾臟病（CKD）市场
  • 欧洲慢性肾臟病（CKD）市场
  • 亚太地区慢性肾臟病(CKD) 市场
  • 其他地区慢性肾臟病（CKD）市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 全球慢性肾臟病(CKD) 市场成长机会（按治疗）
    • 全球慢性肾臟病(CKD) 市场成长机会（依最终用途）
    • 全球慢性肾臟病(CKD) 市场成长机会（按地区）
  • 全球慢性肾臟病（CKD）市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 扩大全球慢性肾臟病(CKD) 市场的产能
    • 全球慢性肾臟病(CKD) 市场的合併、收购和合资企业
    • 认证和许可

第7章主要企业概况

  • Baxter International
  • Teva Pharmaceutical Industries
  • AstraZeneca
  • Johnson & Johnson
  • AbbVie
  • Becton
  • Dickinson and Company
  • B. Braun
  • F. Hoffmann-La Roche
  • Pfizer
简介目录

Chronic Kidney Disease Trends and Forecast

The future of the global chronic kidney disease market looks promising with opportunities in the hospital and dialysis center markets. The global chronic kidney disease market is expected to reach an estimated $83.6 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are rising occurence of CKD and usage of technologically advanced products and diagnostics tests.

A more than 150-page report is developed to help in your business decisions.

Chronic Kidney Disease by Segment

The study includes a forecast for the global chronic kidney disease by treatment, end use, and region.

Chronic Kidney Disease Market by Treatment [Shipment Analysis by Value from 2018 to 2030]:

  • Drugs
  • Dialysis

Chronic Kidney Disease Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital
  • Dialysis Center
  • Others

Chronic Kidney Disease Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Chronic Kidney Disease Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies chronic kidney disease companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the chronic kidney disease companies profiled in this report include-

  • Baxter International
  • Teva Pharmaceutical Industries
  • AstraZeneca
  • Johnson & Johnson
  • AbbVie
  • Becton
  • Dickinson and Company
  • B. Braun
  • F. Hoffmann-La Roche
  • Pfizer

Chronic Kidney Disease Market Insights

Lucintel forecasts that drugs are expected to witness the higher growth over the forecast period due to introduction of new drugs and therapies to help healthcare professional to treat patients effectively.

Within this market, hospitals is expected to witness the higher growth as it is equipped with advanced facilities, which are required to treat and manage CKD

APAC is expected to witness highest growth over the forecast period due to the presence of substantial number of patients and increasing demand of quality healthcare in the region.

Features of the Global Chronic Kidney Disease Market

Market Size Estimates: Chronic kidney disease market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Chronic kidney disease market size by treatment, end use, and region in terms of value ($B).

Regional Analysis: Chronic kidney disease market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different treatments, end uses, and regions for the chronic kidney disease market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the chronic kidney disease market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the chronic kidney disease market size?

Answer: The global chronic kidney disease market is expected to reach an estimated $83.6 billion by 2030.

Q2. What is the growth forecast for chronic kidney disease market?

Answer: The global chronic kidney disease market is expected to grow with a CAGR of 6.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the chronic kidney disease market?

Answer: The major drivers for this market are rising occurence of CKD and usage of technologically advanced products and diagnostics tests.

Q4. What are the major segments for chronic kidney disease market?

Answer: The future of the chronic kidney disease market looks promising with opportunities in the hospital and dialysis center markets.

Q5. Who are the key chronic kidney disease market companies?

Answer: Some of the key chronic kidney disease companies are as follows:

  • Baxter International
  • Teva Pharmaceutical Industries
  • AstraZeneca
  • Johnson & Johnson
  • AbbVie
  • Becton
  • Dickinson and Company
  • B. Braun
  • F. Hoffmann-La Roche
  • Pfizer

Q6. Which chronic kidney disease market segment will be the largest in future?

Answer: Lucintel forecasts that drugs are expected to witness the higher growth over the forecast period due to introduction of new drugs and therapies to help healthcare professional to treat patients effectively.

Q7. In chronic kidney disease market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to the presence of substantial number of patients and increasing demand of quality healthcare in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the chronic kidney disease market by treatment (drugs and dialysis), end use (hospital, dialysis center, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Chronic Kidney Disease Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Chronic Kidney Disease Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Chronic Kidney Disease Market by Treatment
    • 3.3.1: Drugs
    • 3.3.2: Dialysis
  • 3.4: Global Chronic Kidney Disease Market by End Use
    • 3.4.1: Hospital
    • 3.4.2: Dialysis Center
    • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Chronic Kidney Disease Market by Region
  • 4.2: North American Chronic Kidney Disease Market
    • 4.2.2: North American Chronic Kidney Disease Market by End Use: Hospital, Dialysis Center, and Others
  • 4.3: European Chronic Kidney Disease Market
    • 4.3.1: European Chronic Kidney Disease Market by Treatment: Drugs and Dialysis
    • 4.3.2: European Chronic Kidney Disease Market by End Use: Hospital, Dialysis Center, and Others
  • 4.4: APAC Chronic Kidney Disease Market
    • 4.4.1: APAC Chronic Kidney Disease Market by Treatment: Drugs and Dialysis
    • 4.4.2: APAC Chronic Kidney Disease Market by End Use: Hospital, Dialysis Center, and Others
  • 4.5: ROW Chronic Kidney Disease Market
    • 4.5.1: ROW Chronic Kidney Disease Market by Treatment: Drugs and Dialysis
    • 4.5.2: ROW Chronic Kidney Disease Market by End Use: Hospital, Dialysis Center, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Chronic Kidney Disease Market by Treatment
    • 6.1.2: Growth Opportunities for the Global Chronic Kidney Disease Market by End Use
    • 6.1.3: Growth Opportunities for the Global Chronic Kidney Disease Market by Region
  • 6.2: Emerging Trends in the Global Chronic Kidney Disease Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Chronic Kidney Disease Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Chronic Kidney Disease Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Baxter International
  • 7.2: Teva Pharmaceutical Industries
  • 7.3: AstraZeneca
  • 7.4: Johnson & Johnson
  • 7.5: AbbVie
  • 7.6: Becton
  • 7.7: Dickinson and Company
  • 7.8: B. Braun
  • 7.9: F. Hoffmann-La Roche
  • 7.10: Pfizer